Rexulti Approved to Treat Schizophrenia in Pediatric Patients
December 27, 2021Nitroglycerin Lingual Spray for Chest Pain Recalled
December 27, 2021December 27, 2021 – Taro Pharmaceuticals has recalled one lot of Clobetasol Propionate Ointment USP, 0.05%, after identifying the presence of Ralstonia pickettii bacteria through routine testing.
- There is no impact to members through Benecard Central Fill.
- Clobetasol propionate ointment 0.05% is indicated to relieve inflammation and itching caused by skin conditions that respond to corticosteroid treatment. R. pickettii can be found naturally in soil and water, and for healthy individuals with intact skin, is unlikely to cause infection. However, an individual who is immunocompromised or whose skin is not intact (abrasions, sunburn, psoriasis, etc.) may develop a potentially life-threatening systemic infection if exposed to the bacteria through use of contaminated corticosteroid ointment. As of the recall date, Taro had received no reports of adverse events related to the affected product.
- Consumers should contact Taro at 1-866-923-4914 or TaroPVUS@taro.com for help with questions about the recall. Taro advises consumers to contact their healthcare provider if they have experienced any problems that may be related to using the affected product.
- Additional information can be found in the full recall notice, located on the FDA website.